---
title: "Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296365482.md"
description: "The competition for weight-loss pills between Eli Lilly and Novo Nordisk is anticipated to contribute to the growing market for obesity drugs, estimated to reach $200 billion. This showdown in the weight-loss pills market is making headlines as the two pharmaceutical giants vie for a larger share of this lucrative industry."
datetime: "2026-08-19T13:28:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296365482.md)
  - [en](https://longbridge.com/en/news/296365482.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296365482.md)
generator: "portal-rs"
---

# Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market

The competition for weight-loss pills between Eli Lilly and Novo Nordisk is anticipated to contribute to the growing market for obesity drugs, estimated to reach $200 billion. This showdown in the weight-loss pills market is making headlines as the two pharmaceutical giants vie for a larger share of this lucrative industry.

### Related Stocks

- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [NVOX.US](https://longbridge.com/en/quote/NVOX.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [NVOH.US](https://longbridge.com/en/quote/NVOH.US.md)

## Related News & Research

- [Obesity Drug Alert: Eli Lilly Study Shows Sustained Zepbound Treatment Reduces Hospital Visits, Medical Costs](https://longbridge.com/en/news/297082109.md)
- [Eli Lilly Is Acquiring Merdia Biosciences for Up to $2.88 Billion. Here's What That Means for Investors.](https://longbridge.com/en/news/297565544.md)
- [Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?](https://longbridge.com/en/news/297409652.md)
- [Lilly's $9.94 Billion Mounjaro Franchise Wins a Heart-Risk Label](https://longbridge.com/en/news/297356212.md)
- [Novo's Wegovy Pill Enters China Behind Lilly](https://longbridge.com/en/news/297358844.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**